Tremfya 200 mg/2 ml, Injektionslösung im Fertigpen

7680674900023 CH-67490 L04AC16 07.15.0.

Reimbursement limitations:

TREMFYA PEN

Psoriasis en plaque
Traitement de patients adultes atteints de formes sévères de psoriasis en plaque, …

Tremfya 200 mg/2 ml, Injektionslösung im Fertigpen
google

Details

Product number
6749002
CPT
-
Packaging group
1
Unit
Injektor(en), vorgefüllt/Pen
Composition
guselkumabum 200 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml.

Articles (1)

Tremfya 200 mg/2 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2090.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2025

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
67490
Drug name
Tremfya, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L04AC16
Authorization status
Z
Dispensation category
B
First authorization
20/12/2019
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Plaque Psoriasis, Psoriasis-Arthritis, Morbus Crohn, Colitis ulcerosa

Packaging details

Description (FR)
TREMFYA 200 mg/2 ml sol inj 200 mg 1 pce
Description (DE)
TREMFYA 200 mg/2 ml Inj Lös 200 mg 1 Stk
Market launch
26/08/2025
Narcotic (BTM)
No

Other packaging sizes

TREMFYA sol inj 100 mg/ml stylo pré 1 ml
1 INJ
View